In a secondary analysis from a randomised, double-blind placebo-controlled trial Dexmedetomidine blocks cholinergic dysregulation in delirium pathogenesis in patients with major surgery
Authors:
Open Access
- 9 March 2023
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-12
Abstract
Dexmedetomidine is an alpha-2 adrenoreceptor agonist with anti-inflammatory and anti-delirogenic properties. Pathogenesis of postoperative delirium (POD) includes cholinergic dysfunction and deregulated inflammatory response to surgical trauma. Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are discussed as biomarkers for both POD and severity in acute inflammation. To show whether there is a link between blood cholinesterase activities and dexmedetomidine, we performed a secondary analysis of a randomised, double-blind, placebo-controlled trial that recently showed a lower incidence of POD in the dexmedetomidine group. Abdominal or cardiac surgical patients aged ≥ 60 years were randomised to receive dexmedetomidine or placebo intra- and postoperatively in addition to standard general anaesthesia. We analysed the course of perioperative cholinesterase activities of 56 patients, measured preoperatively and twice postoperatively. Dexmedetomidine resulted in no change in AChE activity and caused a rapid recovery of BChE activity after an initial decrease, while placebo showed a significant decrease in both cholinesterase activities. There were no significant between-group differences at any point in time. From these data it can be assumed that dexmedetomidine could alleviate POD via altering the cholinergic anti-inflammatory pathway (CAIP). We advocate for further investigations to show the direct connection between dexmedetomidine and cholinesterase activity.Keywords
Funding Information
- Orionin Tutkimussäätiö
- DFKC
- BIH Charité Digital Clinician Scientist Program funded by the Charité–Universitätsmedizin Berlin and the Berlin Institute of Health at Charité
- Charité - Universitätsmedizin Berlin
This publication has 74 references indexed in Scilit:
- Dexmedetomidine may benefit cognitive function after laparoscopic cholecystectomy in elderly patientsExperimental and Therapeutic Medicine, 2012
- The Cholinergic System and Inflammation: Common Pathways in Delirium PathophysiologyJournal of the American Geriatrics Society, 2012
- Spinal α2-Adrenoceptor-mediated Analgesia in Neuropathic Pain Reflects Brain-derived Nerve Growth Factor and Changes in Spinal Cholinergic Neuronal FunctionAnesthesiology, 2010
- Impaired Mobility, ASA Status and Administration of Tramadol are Risk Factors for Postoperative Delirium in Patients Aged 75 Years or More After Major Abdominal SurgeryAnnals of Surgery, 2010
- Cholinergic Neural Signals to the Spleen Down-Regulate Leukocyte Trafficking via CD11bThe Journal of Immunology, 2009
- Effects of dexmedetomidine on propofol and remifentanil infusion rates during total intravenous anesthesia for spine surgery in adolescentsPediatric Anesthesia, 2008
- Dexmedetomidine: a review of clinical applicationsCurrent Opinion in Anaesthesiology, 2008
- Intraoperative infusion of dexmedetomidine reduces perioperative analgesic requirementsCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2006
- Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsisJournal of Experimental Medicine, 2006
- Impaired Executive Function Is Associated with Delirium After Coronary Artery Bypass Graft SurgeryJournal of the American Geriatrics Society, 2006